Patents by Inventor Christopher Elkins
Christopher Elkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7959847Abstract: Methods and systems of stereolithography for building cost-efficient and time-saving multi-material, multi-functional and multi-colored prototypes, models and devices configured for intermediate washing and curing/drying is disclosed including: laser(s), liquid and/or platform level sensing system(s), controllable optical system(s), moveable platform(s), elevator platform(s), recoating system(s) and at least one polymer retaining receptacle. Multiple polymer retaining receptacles may be arranged in a moveable apparatus, wherein each receptacle is adapted to actively/passively maintain a uniform, desired level of polymer by including a recoating device and a material fill/remove system. The platform is movably accessible to the polymer retaining receptacle(s), elevator mechanism(s) and washing and curing/drying area(s) which may be housed in a shielded enclosure(s).Type: GrantFiled: February 19, 2009Date of Patent: June 14, 2011Assignee: The Board of Regents of the University of Texas SystemInventors: Ryan Wicker, Francisco Medina, Christopher Elkins
-
Publication number: 20110059292Abstract: A preferred embodiment of the present invention provides a method and system for building cost-efficient biocompatible hydrogel constructs using stereolithography. Hydrogel constructs may be used in, for example, multi-lumen nerve regeneration conduits and other tissue engineering scaffolds with embedded channel architecture that facilitate tissue regeneration through possible incorporation of precisely located bioactive agents, cells, and other desired inert and/or active chemical agents and devices. Another preferred embodiment of the present invention provides a method of fabricating a hydrogel construct comprising: solidifying a first solution into a first construct layer with a first energy dosage using stereolithography, the first solution comprising: a first polymer; and a first photoinitiator, wherein the first polymer and first photoinitiator are of a first concentration.Type: ApplicationFiled: August 24, 2010Publication date: March 10, 2011Inventors: Ryan Wicker, Francisco Medina, Karina Arcaute, Luis Ochoa, Christopher Elkins, Brenda Mann
-
Patent number: 7780897Abstract: A preferred embodiment of the present invention provides a method and system for building cost-efficient biocompatible hydrogel constructs using stereolithography. Hydrogel constructs may be used in, for example, multi-lumen nerve regeneration conduits and other tissue engineering scaffolds with embedded channel architecture that facilitate tissue regeneration through possible incorporation of precisely located bioactive agents, cells, and other desired inert and/or active chemical agents and devices. Another preferred embodiment of the present invention provides a method of fabricating a hydrogel construct comprising: solidifying a first solution into a first construct layer with a first energy dosage using stereolithography, the first solution comprising: a first polymer; and a first photoinitiator, wherein the first polymer and first photoinitiator are of a first concentration.Type: GrantFiled: April 22, 2005Date of Patent: August 24, 2010Assignees: Board of Regents, The University of Texas System, Keck Graduate InstituteInventors: Ryan Wicker, Francisco Medina, Karina Arcaute, Luis Ochoa, Christopher Elkins, Brenda Mann
-
Publication number: 20090179355Abstract: Methods and systems of stereolithography for building cost-efficient and time-saving multi-material, multi-functional and multi-colored prototypes, models and devices configured for intermediate washing and curing/drying is disclosed including: laser(s), liquid and/or platform level sensing system(s), controllable optical system(s), moveable platform(s), elevator platform(s), recoating system(s) and at least one polymer retaining receptacle. Multiple polymer retaining receptacles may be arranged in a moveable apparatus, wherein each receptacle is adapted to actively/passively maintain a uniform, desired level of polymer by including a recoating device and a material fill/remove system. The platform is movably accessible to the polymer retaining receptacle(s), elevator mechanism(s) and washing and curing/drying area(s) which may be housed in a shielded enclosure(s).Type: ApplicationFiled: February 19, 2009Publication date: July 16, 2009Inventors: Ryan Wicker, Francisco Medina, Christopher Elkins
-
Patent number: 7556490Abstract: Methods and systems of stereolithography for building cost-efficient and time-saving multi-material, multi-functional and multi-colored prototypes, models and devices configured for intermediate washing and curing/drying is disclosed including: laser(s), liquid and/or platform level sensing system(s), controllable optical system(s), moveable platform(s), elevator platform(s), recoating system(s) and at least one polymer retaining receptacle. Multiple polymer retaining receptacles may be arranged in a moveable apparatus, wherein each receptacle is adapted to actively/passively maintain a uniform, desired level of polymer by including a recoating device and a material fill/remove system. The platform is movably accessible to the polymer retaining receptacle(s), elevator mechanism(s) and washing and curing/drying area(s) which may be housed in a shielded enclosure(s).Type: GrantFiled: July 30, 2004Date of Patent: July 7, 2009Assignee: Board of Regents, the University of Texas SystemInventors: Ryan Wicker, Francisco Medina, Christopher Elkins
-
Publication number: 20090035779Abstract: Systems and methods for determining cross-talk coefficients in curves, such as sigmoid-type or growth curves, and PCR curves and nucleic acid melting curves in particular, as well as for applying the cross-talk coefficients to produce cross-talk corrected data sets using a linear subtractive model. Cross-talk signal coefficients are determined using cross-talk data acquired across the entire signal acquisition range. Analyzing across all of the signal curve data provides for a more robust cross-talk correction across the entire data acquisition range. A linear subtractive model is used to correct data sets having cross-talk components.Type: ApplicationFiled: June 27, 2008Publication date: February 5, 2009Applicant: Roche Molecular Systems, Inc.Inventors: Ronald T. Kurnik, Aditya Sane, Christopher Elkin
-
Publication number: 20070182517Abstract: The present disclosure provides a high performance hybrid magnetic structure made from a combination of permanent magnets and ferromagnetic pole materials which are assembled in a predetermined array. The hybrid magnetic structure provides means for separation and other biotechnology applications involving holding, manipulation, or separation of magnetic or magnetizable molecular structures and targets. Also disclosed are further improvements to aspects of the hybrid magnetic structure, including additional elements and for adapting the use of the hybrid magnetic structure for use in biotechnology and high throughput processes.Type: ApplicationFiled: November 9, 2006Publication date: August 9, 2007Inventors: David Humphries, Martin Pollard, Christopher Elkin
-
Publication number: 20070098594Abstract: Analytical multi-spectral optical detection systems and methods. A light source provides one or multiple lines (e.g., discrete wavelengths) of high spectral purity excitation light that is optically coupled to a sample via delivery fiber optic cables. Emission light is collected and provided to an emission detector, such as a diffraction gradient spectrophotometer emission detector, using collection fiber optic cables bundled with the delivery fiber optic cables in a probe interface positioned proximal a sample holder. The probe interface may be scanned over one or more samples, or one or more samples may be scanned proximal a fixed interface probe. Multiple excitation wavelengths allows for simultaneous excitation and detection of multiple fluorescent dyes in the visible spectrum. This increases sample throughput and reduces signal variations associated with signal acquisition at different times.Type: ApplicationFiled: November 3, 2005Publication date: May 3, 2007Applicant: Roche Molecular Systems, Inc.Inventors: Christopher Elkin, William Hoover, Ronald Kurnik
-
Publication number: 20060237880Abstract: A preferred embodiment of the present invention provides a method and system for building cost-efficient biocompatible hydrogel constructs using stereolithography. Hydrogel constructs may be used in, for example, multi-lumen nerve regeneration conduits and other tissue engineering scaffolds with embedded channel architecture that facilitate tissue regeneration through possible incorporation of precisely located bioactive agents, cells, and other desired inert and/or active chemical agents and devices. Another preferred embodiment of the present invention provides a method of fabricating a hydrogel construct comprising: solidifying a first solution into a first construct layer with a first energy dosage using stereolithography, the first solution comprising: a first polymer; and a first photoinitiator, wherein the first polymer and first photoinitiator are of a first concentration.Type: ApplicationFiled: April 22, 2005Publication date: October 26, 2006Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Ryan Wicker, Francisco Medina, Karina Arcaute, Luis Ochoa, Christopher Elkins, Brenda Mann
-
Patent number: 7101989Abstract: DsrA is an outer membrane protein of H. ducreyi that confers serum resistance to the bacteria. Isolated polynucleotides encoding the protein, end expression vectors and host cells encoding the same, are described. Also described is a mutant H. ducreyi strain that does not express DsrA. Vaccines against H. ducreyi and methods of using the same are also described.Type: GrantFiled: July 7, 2000Date of Patent: September 5, 2006Assignee: University of North Carolina at Chapel HillInventor: Christopher Elkins
-
Publication number: 20060038648Abstract: The present disclosure provides a high performance hybrid magnetic structure made from a combination of permanent magnets and ferromagnetic pole materials which are assembled in a predetermined array. The hybrid magnetic structure provides means for separation and other biotechnology applications involving holding, manipulation, or separation of magnetic or magnetizable molecular structures and targets. Also disclosed are: a method of assembling the hybrid magnetic plates, a high throughput protocol featuring the hybrid magnetic structure, and other embodiments of the ferromagnetic pole shape, attachment and adapter interfaces for adapting the use of the hybrid magnetic structure for use with liquid handling and other robots for use in high throughput processes.Type: ApplicationFiled: October 11, 2005Publication date: February 23, 2006Inventors: David Humphries, Martin Pollard, Christopher Elkin
-
Publication number: 20060022379Abstract: Methods and systems of stereolithography for building cost-efficient and time-saving multi-material, multi-functional and multi-colored prototypes, models and devices configured for intermediate washing and curing/drying is disclosed including: laser(s), liquid and/or platform level sensing system(s), controllable optical system(s), moveable platform(s), elevator platform(s), recoating system(s) and at least one polymer retaining receptacle. Multiple polymer retaining receptacles may be arranged in a moveable apparatus, wherein each receptacle is adapted to actively/passively maintain a uniform, desired level of polymer by including a recoating device and a material fill/remove system. The platform is movably accessible to the polymer retaining receptacle(s), elevator mechanism(s) and washing and curing/drying area(s) which may be housed in a shielded enclosure(s).Type: ApplicationFiled: July 30, 2004Publication date: February 2, 2006Applicant: Board of Regents, The University of Texas SystemInventors: Ryan Wicker, Francisco Medina, Christopher Elkins
-
Publication number: 20050226821Abstract: Oligomers of L-arginine may be used to provide prophylactic or therapeutic cosmetic or other enhancements to keratinous tissues such as skin, hair, lips and gums through vasodilation. Topical compositions preferably comprise (a) an enhancing effective amount of an oligomer having from 7 to 15 subunits, each subunit consisting of a member of the group selected from L-arginine and physiologically acceptable salts of L-arginine that enhance vasodilation through production of nitric oxide, and (b) a cosmetically or dermatologically acceptable vehicle.Type: ApplicationFiled: February 21, 2003Publication date: October 13, 2005Inventors: Jacob Waugh, Michael Dake, Christopher Elkins, Pamela Cifra
-
Publication number: 20040157921Abstract: Methods of altering properties of tissues, by providing an effective modifying amount of zinc, which may be in the form of zinc ions. This is accomplished through the use of topical compositions containing one or more zinc-containing components such as salts and/or other zinc compounds or complexes, particularly zinc acetate.Type: ApplicationFiled: October 22, 2003Publication date: August 12, 2004Applicant: Essentia Biosystems, Inc.Inventors: Pamela Cifra, Michael D. Dake, Christopher Elkins, Jacob M. Waugh
-
Publication number: 20040131700Abstract: Implantable medical devices using zinc, and methods therefore, provide one or more advantageous effects to a tissue. In one embodiment, at least one zinc-containing component is coupled with a stent via one or more zinc chelators to enhance resistance of the stent to plaque formation and in-stent restenosis. Elastin production may also be enhanced by devices coupled with zinc. Enhanced elastin production may be used, for example, to treat a blood vessel in location at or near an aneurysm. In some embodiments, both elastin production and plaque resistance are enhanced. For example, zinc may be applied via a gel or other carrier substance to a venous graft for enhancing elastin and resisting plaque formation. Implantable devices coupled with zinc may provide improved results of medical and surgical procedures involving implantable devices, thus reducing the need for repeat procedures.Type: ApplicationFiled: October 22, 2003Publication date: July 8, 2004Applicant: Essentia Biosystems, Inc.Inventors: Pamela Cifra, Michael D. Dake, Christopher Elkins, Jacob M. Waugh